#United States #San Francisco #CathWorks #FFRangio #TCT 2025

CathWorks to Make a Splash at TCT 2025

CathWorks, a pioneer in digital health technologies, has outlined a dynamic program for the upcoming TCT 2025 conference, set to take place from October 25 to 28 at the Moscone Center in San Francisco, California. As a focal point of this year’s conference, the CathWorks FFRangio® System will be prominently featured in numerous scientific sessions, live case demonstrations, and an exclusive academic satellite program, showcasing advancements in cardiovascular treatment.

Key Highlights of the Schedule

Scientific Presentations

Among the numerous presentations, notable contributions include:

• - Dr. Kazuhiro Dan from Ichinomiyanishi Hospital in Japan will present insights from his study on FFRangio Sizing Tool Guided Percutaneous Coronary Intervention during Monday morning’s session.
• - Afternoon sessions on Monday will see Dr. Pedro Carvalho from the Minneapolis Heart Institute Foundation discussing the Clinical Implementation of Angiography-Derived Fractional Flow Reserve with an emphasis on multicenter experiences within the US. He will also share comparisons between predicted post-PCI fractional flow reserve and observed angiographic results from CT-based virtual PCI studies.

Live Cases

Two engaging live case demonstrations are scheduled:

• - On Monday, Dr. William Fearon and Dr. Brian Kim of Stanford Health Care will lead a session on Intravascular Imaging and Physiology.
• - On Tuesday, Dr. Margaret McEntergart and Dr. Jaikirshan Khatri from Columbia University Irving Medical Center will perform another live case during the same session. These live cases will provide attendees with unique insights into real-time clinical applications of the FFRangio System.

Academic Satellite Program

An exciting lunchtime academic satellite program on Sunday, titled CathWorks FFRangio: Proven Outcomes without Compromise or Complications, will be chaired by Dr. Martin Leon from Columbia University. This session will include input from a panel of esteemed experts, including leaders from the ALL-RISE® study. They will discuss the latest clinical evidence and highlight how the FFRangio System compares to other angio-based technologies for informed decision-making in treating coronary artery disease.

A New Era in Interventional Cardiology

Ramin Mousavi, President and CEO of CathWorks, expresses enthusiasm about the company’s influential presence at TCT 2025. “This underscores a significant shift within the interventional cardiology community towards non-invasive physiological solutions that empower better treatment decisions. Our aim is to establish FFRangio as the standard of care worldwide, elevating the role of coronary physiology in patient treatment,” he remarked.

Engaging With CathWorks

Visitors are invited to explore the latest innovations and demonstrations at the CathWorks booth (#1461) during the conference. For additional details about events at TCT 2025, individuals can visit the dedicated event page on CathWorks' website.
CathWorks continues to reshape cardiovascular diagnosis and treatment paradigms with the innovative FFRangio® System, which utilizes advanced artificial intelligence and computational science, transforming routine angiograms into critical physiological insights quickly and reliably.

About CathWorks

CathWorks is recognized for its advancements in digital health innovations designed to improve patient outcomes globally. By offering reliable intraprocedural FFRangio values through standard angiograms, the FFRangio System eliminates the necessity for invasive pressure wires and drug-induced stimulation, representing a transformative approach in the diagnosis and management of cardiovascular diseases. For further information, visit www.cath.works or follow them on LinkedIn.